Tools dating back 11,000 years found on Skye
Karen Hardy, Professor of Prehistoric Archaeology at the University of Glasgow, led a team of archaeologists and scientists which has published its findings in The Journal of Quaternary Science.She said: "This is a hugely significant discovery which offers a new perspective on the earliest human occupation yet known of north-west Scotland."During the LUP period when they tools are believed to have been made, much of western Scotland was buried under ice.Prof Hardy said groups of nomadic hunter-gatherers, most likely of the Ahrensburgian culture from northern Europe, would have crossed the Doggerland area now covered by the North Sea and established themselves on Skye. "The journey made by these pioneering people who left their lowland territories in mainland Europe to travel northwards into the unknown is the ultimate adventure story," she said."As they journeyed northwards, most likely following animal herds, they eventually reached Scotland, where the western landscape was dramatically changing as glaciers melted and the land rebounded as it recovered from the weight of the ice."A good example of the volatility they would have encountered can be found in Glen Roy, where the world-famous Parallel Roads provide physical testament to the huge landscape changes and cataclysmic floods that they would have encountered as they travelled across Scotland."Once they reached Skye, the early settlers crafted tools from stone found locally.Scientists believe they deliberately chose to base themselves close to coastal and river resources as well as natural materials like ochre, which was highly valued by ancient cultures.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
4 days ago
- Daily Mirror
Breakthrough in breast cancer research could stop the disease from spreading
The discovery offers new hope in the fight against breast cancer, as it could detect and stop the spread of the disease before it becomes incurable Scientists have achieved a significant breakthrough in the battle against breast cancer by dismantling the very components that enable the deadly disease to metastasise. Researchers have discovered that cancer alters the metabolism of certain immune cells, causing them to release a metabolite known as uracil, which aids in constructing a 'scaffold' within distant organs, facilitating the growth of secondary tumours. By inhibiting the enzyme uridine phosphorylase-1 (UPP1), responsible for producing uracil, scientists were able to prevent this 'scaffold' from forming in mice and rejuvenated the immune system's capacity to eliminate secondary cancer cells, thereby thwarting metastasis. This groundbreaking work was carried out in the laboratories of Professor Jim Norman and Professor Karen Blyth at the Cancer Research UK Scotland Institute and the University of Glasgow. This discovery paves the way for potentially potent new methods to combat cancer – identifying uracil in the bloodstream could signal early indications of cancer metastasis, while impeding UPP1 with medication could halt its progression before it even begins. The study's lead author, Dr Cassie Clarke, from the Cancer Research UK Scotland Institute and University of Glasgow, said: "This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives." Published in Embo Reports, the research indicates that crucial metabolic alterations take place prior to the dissemination of cancer, presenting an essential opportunity for intervention. Identifying these alterations at an early stage could enable treatments to prevent cancer cells from migrating throughout the body and establishing tumours in different locations. Dr Catherine Elliott, Cancer Research UK's director of research, explained: "Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. However, metastasis - when cancer spreads - is a major factor in breast cancer becoming harder to treat especially if the cancer returns months or even many years later. "This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones." With approximately 56,800 people receiving a breast cancer diagnosis in the United Kingdom annually and roughly 11,300 people dying from it each year, discovering innovative approaches to combat it remains crucial. Due to research breakthroughs, breast cancer has evolved into a significantly more manageable illness, yet when it metastasises to different parts of the body, effective control becomes increasingly challenging. Comprehending the mechanisms behind breast cancer's spread is essential to preventing the disease from becoming uncontrollable with existing treatments. The research team is now delving deeper into precisely how UPP1 alters immune cell behaviour, examining the function of immune cell metabolism in early breast cancer development, and evaluating the potential of medications that inhibit immune cell metabolism to prevent cancer onset. Simon Vincent, the chief scientific officer at Breast Cancer Now, said: "This is an exciting piece of joint research that expands our understanding of how secondary breast cancer develops. "The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. "In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. "Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital."
Daily Record
5 days ago
- Daily Record
Scots scientists make breast cancer discovery that could stop disease spreading
The discovery could offer patients a vital new window for cancer intervention. A team of Scots scientists have made a groundbreaking new discovery which could help stop the spread of breast cancer - one of the leading causes of death from the disease. Under the research, conducted by experts at the Cancer Research UK Scotland Institute and the University of Glasgow, patients could be offered a vital new window for intervention. The study focused on how breast cancer changes the immune system so it can't tackle cancer cells as they begin to spread. The researchers found that cancer changes the metabolism (the way cells make and use energy) of specific immune cells resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. It opens the door to new potentially powerful new tools to tackle cancer - detecting uracil in the blood could help spot early signs of cancer spread then blocking UPP1 with drugs could stop the spread before it starts. The study was conducted in the labs of Professor Jim Norman and Professor Karen Blyth at the Cancer Research UK Scotland Institute and the University of Glasgow. Study lead Dr Cassie Clarke, of the Cancer Research UK Scotland Institute and University of Glasgow, said: "This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' Every year, around 56,800 people are diagnosed with breast cancer in United Kingdom. Around 11,300 people sadly lose their lives to the disease. Thanks to research, breast cancer has become a far more treatable disease, but once it spreads to other areas within the body it becomes harder to control effectively. Understanding how and why breast cancer spreads is key to preventing the disease becoming unmanageable with current therapies. Cancer Research UK's Director of Research, Dr Catherine Elliott, said: ' Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. 'However, metastasis - when cancer spreads - is a major factor in breast cancer becoming harder to treat especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'This is an exciting piece of joint research that expands our understanding of how secondary breast cancer develops. 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital."
Times
5 days ago
- Times
Scientists' discovery could stop breast cancer spreading
Scottish scientists have made a discovery that could help stop breast cancer spreading to other parts of the body. Experts at Cancer Research UK Scotland Institute and the University of Glasgow have found there are key metabolic changes that take place before tumours grow elsewhere. Their work is being hailed as a significant breakthrough because it is often cancer moving from the breast that kills patients. • How I told my sons that I had a rare form of breast cancer Researchers writing in the journal EMBO Reports said identifying the metabolic changes offered a vital window to intervene. Detecting these changes early could allow therapies to stop cancer cells moving around the body and forming tumours elsewhere. Dr Cassie Clarke, lead researcher, said: 'This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' About 56,800 people are diagnosed with breast cancer in the United Kingdom each year and 11,300 people lose their lives to the disease. Dr Catherine Elliott, Cancer Research UK's director of research, said: 'Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. • Why the way we diagnose, label and treat cancer is changing 'However, metastasis — when cancer spreads — is a major factor in breast cancer becoming harder to treat, especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' The study focused on how breast cancer changes the immune system so it cannot tackle cancer cells as they begin their spread. The researchers found that cancer changes the metabolism — the way cells make and use energy — of specific immune cells, resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. This opens the door to potentially powerful new tools to tackle cancer. Detecting uracil in the blood could help spot early signs of cancer spread, while blocking UPP1 with drugs could stop the spread before it starts. • The Times View: It is time to be optimistic about cancer The research was funded by Cancer Research UK, the Wellcome Trust, the Medical Research Council, Breast Cancer Now and Pancreatic Cancer UK. Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital.' The team are further investigating exactly how UPP1 changes the behaviour of immune cells, exploring the role of immune cell metabolism in early breast cancer initiation, and testing the ability of drugs that block immune cell metabolism to prevent cancer occurring.
